Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 6 387-400, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Cancer and infection: estimates of the attributable fraction in 1990

P Pisani, DM Parkin, N Munoz and J Ferlay
Unit of Descriptive Epidemiology, Lyon, France.

Various estimates of the proportion of all cancers attributable to infections have been proposed but none have been numerically justified. We have reviewed the evidence for "causality" with respect to infectious agents linked with cancer and estimated the fraction of all cancer cases concerned that are attributable to it. The etiological fraction was applied to the estimated annual incidence of cancer at each specific site in 1990, and the number of attributable cases was obtained. We estimate that 15.6% (1,450,000 cases) of the worldwide incidence of cancer in 1990 can be attributed to infection with either the hepatitis B and C viruses, the human papillomaviruses, EBV, human T-cell lymphotrophic virus I, HIV, the bacterium Helicobacter pylori, schistosomes, or liver flukes. There would be 21% fewer cases of cancer in developing countries (1,000,000 fewer cases per year) and 9% fewer cases in developed countries (375,000 fewer cases per year) if these infectious diseases were prevented. The attributable fraction at the specific sites varies from 89% of cervix cancers attributable to the papillomaviruses to 1% of all leukemias attributable to human T-cell lymphotrophic virus I.

This article has been cited by other articles:

				V. Laniosz, K. C. Nguyen, and P. I. Meneses Bovine Papillomavirus Type 1 Infection Is Mediated by SNARE Syntaxin 18 J. Virol., July 15, 2007; 81(14): 7435 - 7448. [Abstract] [Full Text] [PDF]

				D. Schottenfeld and J. Beebe-Dimmer Alleviating the Burden of Cancer: A Perspective on Advances, Challenges, and Future Directions. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2049 - 2055. [Abstract] [Full Text] [PDF]

				G. D. Kirk, E. Bah, and R. Montesano Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082. [Abstract] [Full Text] [PDF]

				D. R. Lowy Human Papillomaviruses: What They Are and What They Do Am. Assoc. Cancer Res. Educ. Book, April 1, 2006; 2006(1): 275 - 278. [Full Text] [PDF]

				D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF]

				S. T Goldstein, F. Zhou, S. C Hadler, B. P Bell, E. E Mast, and H. S Margolis A mathematical model to estimate global hepatitis B disease burden and vaccination impact Int. J. Epidemiol., December 1, 2005; 34(6): 1329 - 1339. [Abstract] [Full Text] [PDF]

				A. Altieri, J. L. Bermejo, and K. Hemminki Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database Blood, July 15, 2005; 106(2): 668 - 672. [Abstract] [Full Text] [PDF]

				M. Inoue, I. Yoshimi, T. Sobue, S. Tsugane, and For the JPHC Study Group Influence of Coffee Drinking on Subsequent Risk of Hepatocellular Carcinoma: A Prospective Study in Japan J Natl Cancer Inst, February 16, 2005; 97(4): 293 - 300. [Abstract] [Full Text] [PDF]

				G. D. Kirk, P. C. Turner, Y. Gong, O. A. Lesi, M. Mendy, J. J. Goedert, A. J. Hall, H. Whittle, P. Hainaut, R. Montesano, et al. Hepatocellular Carcinoma and Polymorphisms in Carcinogen-Metabolizing and DNA Repair Enzymes in a Population with Aflatoxin Exposure and Hepatitis B Virus Endemicity Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 373 - 379. [Abstract] [Full Text] [PDF]

				P. Correa Commentary: Is prostate cancer an infectious disease? Int. J. Epidemiol., February 1, 2005; 34(1): 197 - 198. [Full Text] [PDF]

				L. Yang, D. M. Parkin, J. Ferlay, L. Li, and Y. Chen Estimates of Cancer Incidence in China for 2000 and Projections for 2005 Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 243 - 250. [Abstract] [Full Text] [PDF]

				J. W. Fahey, A. Munoz, Y. Matsuzaki, H. Suzuki, P. Talalay, M. Tauchi, S. Zhang, C. Hurt, and A. Yanaka Dietary Amelioration of Helicobacter pylori Infection: Design Criteria for a Clinical Trial Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1610 - 1616. [Abstract] [Full Text] [PDF]

				H Eguchi, S Carpentier, S S Kim, and S F Moss p27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori Gut, June 1, 2004; 53(6): 797 - 804. [Abstract] [Full Text] [PDF]

				J.-L. Roh, M.-W. Sung, S.-W. Park, D.-S. Heo, D. W. Lee, and K. H. Kim Celecoxib Can Prevent Tumor Growth and Distant Metastasis in Postoperative Setting Cancer Res., May 1, 2004; 64(9): 3230 - 3235. [Abstract] [Full Text] [PDF]

				R Malekzadeh, M Sotoudeh, M H Derakhshan, J Mikaeli, A Yazdanbod, S Merat, A Yoonessi, M Tavangar, B A. Abedi, R Sotoudehmanesh, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran J. Clin. Pathol., January 1, 2004; 57(1): 37 - 42. [Abstract] [Full Text] [PDF]

				A. J Hall and C. P Wild Liver cancer in low and middle income countries BMJ, May 10, 2003; 326(7397): 994 - 995. [Full Text] [PDF]

				G. H. Cassell and J. Mekalanos Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic Resistance JAMA, February 7, 2001; 285(5): 601 - 605. [Abstract] [Full Text] [PDF]

				C. Imrie, M. Rowland, B. Bourke, and B. Drumm Is Helicobacter pylori Infection in Childhood a Risk Factor for Gastric Cancer? Pediatrics, February 1, 2001; 107(2): 373 - 380. [Abstract] [Full Text]

				T. Sasagawa, W. Basha, H. Yamazaki, and M. Inoue High-Risk and Multiple Human Papillomavirus Infections Associated with Cervical Abnormalities in Japanese Women Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 45 - 52. [Abstract] [Full Text]

				P. Correa, E. T. H. Fontham, J. C. Bravo, L. E. Bravo, B. Ruiz, G. Zarama, J. L. Realpe, G. T. Malcom, D. Li, W. D. Johnson, et al. Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy J Natl Cancer Inst, December 6, 2000; 92(23): 1881 - 1888. [Abstract] [Full Text] [PDF]

				M.-J. Oh, J.-H. Choi, I. H. Kim, Y. H. Lee, J. Y. Huh, Y. K. Park, K. W. Lee, S. Y. Chough, K. S. Joo, B. S. Ku, et al. Detection of Epidermal Growth Factor Receptor in the Serum of Patients with Cervical Carcinoma Clin. Cancer Res., December 1, 2000; 6(12): 4760 - 4763. [Abstract] [Full Text]

				A. Murakami, Y. Nakamura, T. Tanaka, K. Kawabata, D. Takahashi, K. Koshimizu, and H. Ohigashi Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation Carcinogenesis, October 1, 2000; 21(10): 1843 - 1850. [Abstract] [Full Text] [PDF]

				J. W. Sellors, J. B. Mahony, J. Kaczorowski, A. Lytwyn, H. Bangura, S. Chong, A. Lorincz, D. M. Dalby, V. Janjusevic, J. L Keller, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada Can. Med. Assoc. J., September 1, 2000; 163(5): 503 - 508. [Abstract] [Full Text] [PDF]

				J. W. Sellors, A. T. Lorincz, J. B. Mahony, I. Mielzynska, A. Lytwyn, P. Roth, M. Howard, S. Chong, D. Daya, W. Chapman, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions Can. Med. Assoc. J., September 1, 2000; 163(5): 513 - 518. [Abstract] [Full Text] [PDF]

				P. Vineis, P. Crosignani, C. Sacerdote, A. Fontana, G. Masala, L. Miligi, O. Nanni, V. Ramazzotti, S. Rodella, E. Stagnaro, et al. Haematopoietic cancer and medical history: a multicentre case control study J. Epidemiol. Community Health, June 1, 2000; 54(6): 431 - 436. [Abstract] [Full Text] [PDF]

				E. A. O'Gara, D. J. Hill, and D. J. Maslin Activities of Garlic Oil, Garlic Powder, and Their Diallyl Constituents against Helicobacter pylori Appl. Envir. Microbiol., May 1, 2000; 66(5): 2269 - 2273. [Abstract] [Full Text]

				K. Hemminki and C. Dong Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin Arch Dermatol, May 1, 2000; 136(5): 647 - 651. [Abstract] [Full Text] [PDF]

				R. Herrero, A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, et al. Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica J Natl Cancer Inst, March 15, 2000; 92(6): 464 - 474. [Abstract] [Full Text] [PDF]

				K. Hemminki and C. Dong Re: Detection of Epstein-Barr Virus in Invasive Breast Cancers J Natl Cancer Inst, December 15, 1999; 91(24): 2126 - 2126. [Full Text] [PDF]

				C. T.K.-H. Stadtlander and J. W. waterbor Molecular epidemiology, pathogenesis and prevention of gastric cancer Carcinogenesis, December 1, 1999; 20(12): 2195 - 2208. [Abstract] [Full Text] [PDF]

				C. Dupuy, D. Buzoni-Gatel, A. Touze, D. Bout, and P. Coursaget Nasal Immunization of Mice with Human Papillomavirus Type 16 (HPV-16) Virus-Like Particles or with the HPV-16 L1 Gene Elicits Specific Cytotoxic T Lymphocytes in Vaginal Draining Lymph Nodes J. Virol., November 1, 1999; 73(11): 9063 - 9071. [Abstract] [Full Text] [PDF]

				S. B Jones Cancer in the developing world: a call to action BMJ, August 21, 1999; 319(7208): 505 - 508. [Full Text]

				A. Ung, T. R. Kramer, M. Schiffman, R. Herrero, M. C. Bratti, R. D. Burk, C. A. Swanson, M. E. Sherman, M. L. Hutchinson, M. Alfaro, et al. Soluble Interleukin 2 Receptor Levels and Cervical Neoplasia: Results from a Population-based Case-Control Study in Costa Rica Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 249 - 253. [Abstract] [Full Text] [PDF]

				M. A. Moore, H. Tsuda, S. Tamano, A. Hagiwara, K. Imaida, T. Shirai, and N. Ito Commentary: Marriage of a Medium-Term Liver Model to Surrogate Markers--A Practical Approach for Risk and Benefit Assessment Toxicol Pathol, March 1, 1999; 27(2): 237 - 242. [Abstract] [PDF]

				A. Touze, S. El Mehdaoui, P.-Y. Sizaret, C. Mougin, N. Muñoz, and P. Coursaget The L1 Major Capsid Protein of Human Papillomavirus Type 16 Variants Affects Yield of Virus-Like Particles Produced in an Insect Cell Expression System J. Clin. Microbiol., July 1, 1998; 36(7): 2046 - 2051. [Abstract] [Full Text]